71. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
9. Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
21.06. - 24.06.2020
Vorträge Montag, 22.06.2020
Tumortherapiefelder/Tumour treating fields
Meeting Abstract
(V013)
[Full Text]
Influence of TTFields dose on tumour progression pattern in the EF-14 trial
Glas M, Bomzon Z, Ballo MT[Full Text]
Meeting Abstract
(V014)
[Full Text]
Investigation of in vitro response to TTFields and related gene expression in 45 human cell lines
Kinzel A, Lavy-Shahaf G, Giladi M, Schneiderman R, Gotlib K, Zeevi E, Porat Y, Munster M, Weinberg U, Kirson E, Palti Y[Full Text]
Meeting Abstract
(V015)
[Full Text]
TTFields disruption of the blood brain barrier – a potential CNS drug delivery approach
Salvador E, Keßler AF, Hörmann J, Burek M, Brami CT, Sela TV, Giladi M, Ernestus RI, Löhr M, Förster C, Hagemann C[Full Text]
Meeting Abstract
(V016)
[Full Text]
TTFields in WHO grade III glioma – post-marketing surveillance analysis suggests favourable tolerance
Keßler AF, Ritz R[Full Text]
Meeting Abstract
(V017)
[Full Text]
Aurora kinase inhibition and radiation therapy enhance the efficacy oftumour treating fields in recurrent glioblastoma treatment
Thalmaier T, Lachmann D, Roosz S, Bartmann P, Jugel W, Hagstotz A, Temme A, Michen S, Krex D[Full Text]
Meeting Abstract
(V018)
[Full Text]
Analysis of a platform for exchange of patients’ expertise in TTFields practice to improve quality-of-life in high-grade glioma patients
Keßler AF, Weiland J, Dufner V, Lilla N, Linsenmann T, Westermaier T, Hagemann C, Ernestus RI, Löhr M, Jentschke E[Full Text]
